NEUMORA THERAPEUTICS INC (NMRA) Stock Analyst Earnings Estimates
NASDAQ:NMRA - Nasdaq - US6409791000 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A 98.16% | N/A 827.32% | N/A 183.51% | N/A 137.14% | N/A 109.18% | N/A 47.34% | |||||||
| EBITDA YoY % growth | -20K | -25.39M -126,850.00% | -79.78M -214.22% | -122.28M -53.27% | -187.526M -53.36% | -262.833M -40.16% | N/A 6.08% | N/A 39.67% | N/A -2.74% | N/A -1.33% | N/A 55.46% | N/A 223.93% | N/A 93.09% | N/A 46.73% | |
| EBIT YoY % growth | -20K | -25.5M -127,400.00% | -80.32M -214.98% | -122.87M -52.98% | -188.194M -53.17% | -263.464M -40.00% | N/A 2.16% | N/A 18.10% | N/A -6.54% | N/A 15.60% | N/A 65.43% | N/A 473.16% | N/A 183.09% | N/A 68.48% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | -1.53 14.22% | N/A 6.11% | N/A 27.10% | N/A 2.44% | N/A 8.15% | N/A 81.52% | N/A 879.41% | N/A 80.38% | N/A 58.44% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.38 -1.54% | -0.36 19.15% | -0.34 7.19% | -0.34 19.05% |
| Revenue Q2Q % growth | ||||
| EBITDA Q2Q % growth | -57.12M 10.05% | -58.14M 23.67% | -59.16M 5.03% | N/A |
| EBIT Q2Q % growth | -60.453M 5.28% | -57.209M 25.36% | -59.021M 6.20% | -45.696M 35.58% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.42 -23.53% | -0.38 | -0.04 | -10.01% |
| Q4 2024 Q2Q % growth | -0.37 47.89% | -0.46 | 0.09 | 18.71% |
| Q3 2024 Q2Q % growth | -0.45 60.53% | -0.40 | -0.05 | -13.12% |
| Q2 2024 Q2Q % growth | -0.37 | -0.38 | 0.01 | 2.34% |
| Q1 2024 Q2Q % growth | -0.34 | -0.35 | 0.01 | 2.53% |
| Q4 2023 Q2Q % growth | -0.71 | -0.56 | -0.15 | -26.56% |
| Q3 2023 Q2Q % growth | -1.14 | -0.37 | -0.77 | -208.32% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 3.43% | 0% | 5.24% |
| Revenue | N/A | N/A | N/A | N/A |